FORTYSSIMO
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79389844
- Registration number
- 7691409
- Mark type
- Stylized text
- Filed
- 18 Jan 2024
- Published for opposition
- 31 Dec 2024
- Registered
- 18 Feb 2025
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, autoimmune diseases, and inflammatory disorders
- Class 042 — Scientific and technological services: Medical and pharmacological research services; medical and scientific research services, namely conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Genmab A/S, DK
- Genmab A/S, DK
- Genmab A/S, DK
Prosecution history
- 19 Sept 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Sept 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Sept 2025 — FINAL DISPOSITION PROCESSED
- 08 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 21 Jul 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 21 Jul 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 May 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Mar 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED